Skip to main content
AAPLMSFTGOOGLMETANVDABRK-BAMZNJPMBACKOCVXOXYAXPCMGV
HoldLens logoHoldLens
← Full ticker page
Signal dossier · Q4 2025

CVS logoCVS

CVS Health · Healthcare

HoldLens verdict · single −100..+100 scale
BUY
+3
on a signed +100 buy scale · WEAK BUY
0 tracked manager buying MODERATE signal.
Unified ConvictionScore · −100..+100
Smart money + insider + track record + trend + concentration + contrarian − dissent − crowding
+3
Buy component
+8
Dissent penalty
−5
Unanimity bonus
0
Quality differential
+0
Info density
+2
Buyers / Sellers
0 / 1
ConvictionScore v5 · 9-layer breakdown
13F superinvestor moves + Form 4 insider trades + 8-K material events. The SEC Signals trilogy.
+3
Smart money (13F)
+2
Insider activity (Form 4)
+0
Track record (CAGR)
+2
Trend streak
+0
Concentration
+4
Contrarian bonus
+0
Event signal (8-K)
+0
− Dissent penalty
−5
− Crowding penalty
−0
Owners: 1·Buyers: 7·Sellers: 9·Buyer-CAGR-weighted expected return: +13.8% ±3.9%·How this is computed
Share this signal

Ownership breadth · 8 quarters

Breadth flat
+0 owners over 8Q
1
0
1
1
1
1
1
1
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25

The number of superinvestors holding this name has been stable for 8 quarters. See the most-owned names across all tracked managers →

Smart money activity

Every tracked 13F move on CVS — grouped by quarter, ranked by manager quality.

Smart money activity
7 buys · 9 sells across tracked 13F filings
Net signal: STRONG SELL
Q4 2025(1 move)
Portfolio manager% portfolio
Joel GreenblattElite
Gotham Asset Management
0.10%
Q3 2025(2 moves)
Portfolio manager% portfolio
Joel GreenblattElite
Gotham Asset Management
0.10%
Bill Nygren
Oakmark Funds
0.10%
Q2 2025(2 moves)
Portfolio manager% portfolio
Joel GreenblattElite
Gotham Asset Management
0.10%
Bill Nygren
Oakmark Funds
0.10%
Q1 2025(1 move)
Portfolio manager% portfolio
Joel GreenblattElite
Gotham Asset Management
0.30%
Q4 2024(3 moves)
Portfolio manager% portfolio
Prem Watsa
Fairfax Financial
7.80%
Joel GreenblattElite
Gotham Asset Management
0.20%
Lee AinslieElite
Maverick Capital
0.00%
Q3 2024(3 moves)
Portfolio manager% portfolio
Lee AinslieElite
Maverick Capital
1.30%
Bill Nygren
Oakmark Funds
0.50%
Joel GreenblattElite
Gotham Asset Management
0.40%
Q2 2024(3 moves)
Portfolio manager% portfolio
Joel GreenblattElite
Gotham Asset Management
0.50%
Bill Nygren
Oakmark Funds
0.50%
Prem Watsa
Fairfax Financial
0.00%
Q1 2024(1 move)
Portfolio manager% portfolio
Michael Burry
Scion Asset Management
0.00%

Insider activity

What the company's own executives and directors are doing — buys are highly bullish.

Latest news

Recent headlines for CVS — context for the moves above.

Who’s betting biggest on CVS

Healthcare sector →→ Ranks #75 of 83 tracked bets

Each bar is one manager’s position size in CVS as a % of their portfolio. Longer bar = bigger conviction bet. T1 badge marks the highest-quality track records.

Prem Watsa fund logoPrem Watsa
5.9%
“Healthcare at reasonable P/E.”

AI thesis

An AI-synthesised investment thesis for CVS, based on the 13F data above. Generated on demand — not stored or pre-computed.

AI thesis
Claude Haiku synthesis of BUY positioning from 1 institutional filers
Powered by Claude Haiku

Generate a 2-paragraph investment thesis synthesising 1 institutional holdings and the +3 conviction score.

Related smart-money signals

Derived from the same 13F filings
Same sector · Healthcare
Top conviction in this sector
  1. 1.NOVONovo Nordisk
    +6
  2. 2.BHCBausch Health
    0
  3. 3.VTRSViatris
    0
  4. 4.UNHUnitedHealth
    -4
  5. 5.DVADaVita
    -6
All Healthcare names →
HoldLens Pro · Founders pricing
Email alerts + conviction scores + alpha attribution
€9/mo founders · cancel anytime
See pricing →
Share the CVS signal
Post LinkedIn Reddit Facebook

The HoldLens signal dossier shows the unified −100..+100 ConvictionScore alongside live prices, multi-quarter trend detection, insider activity, and real-time news. Not investment advice. Methodology.